Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LY333531 Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes

NCT00044395 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00044395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00044395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LY333531 Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
Lead sponsor
Eli Lilly and Company
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2002
Completion date
October 31, 2005
Enrollment
200
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, insulin-dependent, diabetes mellitus, non-insulin-dependent, diabetic neuropathies